Abstract: The disclosure relates generally novel sulfur containing glycerol mono-ester derivatives and methods useful for treating gram positive, gram negative, fungal and envelope viral infections in a patient.
Type:
Grant
Filed:
January 31, 2023
Date of Patent:
January 16, 2024
Assignee:
Niche Biopharmaceuticals LLC
Inventors:
Dayton T. Reardan, Paul Brennan, Patrick Schlievert
Abstract: The disclosure relates generally novel sulfur containing glycerol mono-ester derivatives and methods useful for treating gram positive, gram negative, fungal and envelope viral infections in a patient.
Type:
Application
Filed:
January 31, 2023
Publication date:
June 8, 2023
Applicant:
Niche Biopharmaceuticals LLC
Inventors:
Dayton T. Reardan, Paul Brennan, Patrick Schlievert
Abstract: The disclosure relates generally novel sulfur containing glycerol mono-ester derivatives and methods useful for treating gram positive, gram negative, fungal and envelope viral infections in a patient.
Type:
Grant
Filed:
September 18, 2020
Date of Patent:
February 7, 2023
Assignee:
Niche Biopharmaceuticals LLC
Inventors:
Dayton T. Reardan, Paul Brennan, Patrick Schlievert
Abstract: The disclosure relates generally novel sulfur containing glycerol mono-ester derivatives and methods useful for treating gram positive, gram negative, fungal and envelope viral infections in a patient.
Type:
Grant
Filed:
January 6, 2022
Date of Patent:
June 21, 2022
Assignee:
Niche Biopharmaceuticals LLC
Inventors:
Dayton T. Reardan, Paul Brennan, Patrick Schlievert